ISDA letter to ESMA and NCAs on OTC challenges for EMIR reporting – update

ISDA letter to ESMA and National Competent Authorities (NCAs) providing an update on anticipated challenges for EMIR reporting of OTC Derivatives from February 12, 2014.

Appendix 1: Update on each of the industry issues and challenges advised previously (Appendix 2).
Appendix 2: Original list of industry issues and challenges.

ISDA response to ESMA MiFIR Review Consultation

On July 11, ISDA submitted a response to the European Securities and Markets Authority's (ESMA) fourth package of Level 2 consultation under the Markets in Financial Instruments Regulation Review (MiFIR), on transparency for derivatives, package orders and input/output data for...